|
Status |
Public on May 23, 2013 |
Title |
NLGN3_2 |
Sample type |
RNA |
|
|
Source name |
primary cortical neurons, NLGN3 shRNA
|
Organism |
Mus musculus |
Characteristics |
strain: C57/Bl6J days in vitro: 16 tissue: E16 embryonic cortex treatment: NLGN3 shRNA
|
Extracted molecule |
total RNA |
Extraction protocol |
Trizol extraction of total RNA was performed.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol.
|
|
|
Hybridization protocol |
Five (5) ug of fragmented, biotin-labeled cDNA was hybridized to Affymetrix Mouse Genome 430 2.0 Gene Chips for 18 hours, then washed/stained according to manufacturer's recommendations using the Affymetrix 450 fluidics station.
|
Scan protocol |
Gene chips were scanned using an Affymetrix 3000 array scanner.
|
Description |
2 week shRNA treatment
|
Data processing |
R/Bioconductor was used to apply the Robust Multi-Array Average (RMA) methodology to generate expression values for the combined samples.
|
|
|
Submission date |
May 21, 2013 |
Last update date |
May 23, 2013 |
Contact name |
Thomas A Lanz |
E-mail(s) |
[email protected]
|
Phone |
860-441-3551
|
Organization name |
Pfizer
|
Department |
Global Pathology and Investigative Toxicology
|
Street address |
Eastern Point Rd MS# 8274-1224
|
City |
Groton |
State/province |
CT |
ZIP/Postal code |
06340 |
Country |
USA |
|
|
Platform ID |
GPL1261 |
Series (1) |
GSE47150 |
Microarray profiling of primary neurons transduced with shRNA for multiple ASD-implicated genes |
|